FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Back

2006P-0154: Remove from the Market, the Prescription Version of Xenical (Orlistat, Roche Pharmaceuticals)

C2 GlaxoSmithKline Consumer Healthcare (GSK) and Hoffmann-LaRoche, Inc. (Roche)

Table of Contents

Comment

Attachment 1 - Summary of Comments in Opposition to Public Citizen's Petition Requesting Withdrawal of Prescription Xenical from the Market and the Rejection of Approval of Orlistat Capsules for Over-the-Counter Use (FDA Docket No. 2006P-0154 and 2006P-0154/Sup 1)

Attachment 2 - Orlistat Preclinical and Clinical Summary Report on Colon Cancer

Attachment 3 - Summary of Colon Scientific Advisory Board

Top | Back

Page last updated February 8, 2007 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management